Fortress Biotech, Inc.
FBIONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for FBIO. That does not mean none is planned.
Get an email about FBIO's next catalysts
Track Fortress Biotech (FBIO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
FBIO Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is Fortress Biotech, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Fortress Biotech, Inc. (FBIO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track FBIO biotech catalysts?→
Add FBIO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Fortress Biotech, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.